Open AccessAmiodarone, Lidocaine, or Placebo in Out-of-Hospital Cardiac Arrest
Author(s) -
Peter J. Kudenchuk,
Siobhan P. Brown,
Mohamud Daya,
Thomas D. Rea,
Graham Nichol,
Laurie J. Morrison,
Brian G. Leroux,
Christian Vaillancourt,
Lynn Wittwer,
Clifton W. Callaway,
James Christenson,
Debra Egan,
Joseph P. Ornato,
Myron L. Weisfeldt,
Ian G. Stiell,
Ahamed H. Idris,
Tom P. Aufderheide,
James V. Dunford,
M. Riccardo Colella,
Gary M. Vilke,
Ashley Brienza,
Patrice DesvigneNickens,
Pamela C. Gray,
Randal Gray,
Norman Seals,
Ron Straight,
Paul Dorian
Publication year - 2016
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa1514204
Subject(s) - medicine , lidocaine , amiodarone , placebo , anesthesia , cardiology , atrial fibrillation , pathology , alternative medicine
Antiarrhythmic drugs are used commonly in out-of-hospital cardiac arrest for shock-refractory ventricular fibrillation or pulseless ventricular tachycardia, but without proven survival benefit.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom